Our group previously reported the effective targeting of EGFR-overexpressing pancreatic cancer cells both in vitro and in vivo with gold nanoparticles conjugated with C225 as a targeting agent [24]. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.